Premium Nahrungsergänzungsmittel | artgerecht

TNF-alpha – Function, Diseases & Treatment

TNF-alpha (tumor necrosis factor-alpha) is a pro-inflammatory signaling molecule of the immune system. It plays a central role in inflammatory responses and is linked to numerous autoimmune diseases.

Regular tips about health Regular tips about health

Things worth knowing about "TNF-alpha"

TNF-alpha (tumor necrosis factor-alpha) is a pro-inflammatory signaling molecule of the immune system. It plays a central role in inflammatory responses and is linked to numerous autoimmune diseases.

What is TNF-alpha?

TNF-alpha (tumor necrosis factor-alpha) is a cytokine – a chemical messenger of the immune system – produced mainly by macrophages (a type of immune cell). It belongs to the group of pro-inflammatory cytokines, meaning it promotes inflammatory reactions in the body. TNF-alpha is a key mediator of the innate immune response and influences a wide range of biological processes, from cell proliferation to programmed cell death (apoptosis).

Mechanism of Action

TNF-alpha binds to specific receptors on the surface of cells, known as TNF receptors (TNFR1 and TNFR2). Through these receptors, TNF-alpha activates several intracellular signaling pathways:

NF-κB pathway: Promotes the expression of genes that amplify inflammation.
MAPK pathway: Influences cell growth and differentiation.
Apoptosis pathway: Triggers programmed cell death in certain cell types, particularly tumor cells.

These signaling pathways lead to the release of additional inflammatory mediators and the activation of other immune cells.

Biological Functions

In a healthy body, TNF-alpha serves important protective functions:

Activation of the immune system in response to infections and tissue damage
Defense against bacteria, viruses, and parasites
Regulation of the fever response as a defense mechanism
Contribution to wound healing and tissue repair
Support of the anti-tumor immune response

Clinical Relevance: Diseases Associated with Elevated TNF-alpha

Excessive or chronic secretion of TNF-alpha is associated with a wide range of diseases:

Autoimmune Diseases

Rheumatoid arthritis: Chronic joint inflammation driven by overproduction of TNF-alpha
Crohn's disease and ulcerative colitis: Chronic inflammatory bowel diseases
Psoriasis: Inflammatory skin disease
Ankylosing spondylitis: Inflammatory disease of the spine

Metabolic Diseases

Type 2 diabetes: TNF-alpha can reduce insulin sensitivity and contribute to insulin resistance
Obesity: Adipose tissue produces elevated amounts of TNF-alpha, promoting chronic low-grade inflammation

Other Conditions

Sepsis: A life-threatening overreaction of the immune system involving massive TNF-alpha release
Heart failure: Elevated TNF-alpha levels are observed in chronic heart failure
Cachexia (disease-related wasting): TNF-alpha promotes muscle and fat breakdown in severe illness

Diagnosis and Measurement

TNF-alpha levels in the blood can be measured using ELISA (Enzyme-Linked Immunosorbent Assay) or other immunological testing methods. Elevated values are considered a marker of active inflammatory processes. This measurement is commonly used in rheumatology and gastroenterology to monitor disease activity.

Therapeutic Inhibition: TNF-alpha Blockers

Because TNF-alpha plays a causative role in many diseases, medications have been developed to selectively block this signaling molecule. These are known as TNF-alpha inhibitors (also called anti-TNF therapy) and belong to the class of biologics.

Approved TNF-alpha Inhibitors

Infliximab (monoclonal antibody)
Adalimumab (monoclonal antibody)
Etanercept (soluble TNF receptor fusion protein)
Certolizumab pegol
Golimumab

Side Effects of TNF-alpha Blockers

Because TNF-alpha is an important component of the immune defense, its inhibition can increase the risk of infection. Key side effects include:

Increased susceptibility to infections (especially tuberculosis and opportunistic infections)
Reactivation of latent infections
Injection or infusion site reactions
In rare cases: demyelinating disorders or liver toxicity

References

Tracey K. J., Cerami A. - Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annual Review of Medicine, 1994. https://pubmed.ncbi.nlm.nih.gov/8163555/
Kalliolias G. D., Ivashkiv L. B. - TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nature Reviews Rheumatology, 2016. https://pubmed.ncbi.nlm.nih.gov/26656761/
European Medicines Agency (EMA) - Product information on TNF-alpha inhibitors. https://www.ema.europa.eu/

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category